Neulasta Sales Data

Rank 9 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Neulasta U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 9 -4.90% -6.10%
Q3 2013 9 (1) 4.38% 1.55%
Q2 2013 10 0.21% -1.82%
Q1 2013 10 6.94% 4.11%
Q4 2012 10 -3.54% -4.53%
Q3 2012 10 (1) -1.17% -1.19%
Q2 2012 11 (2) -0.86% 1.21%
Q1 2012 13 (1) 3.33% 1.53%
Q4 2011 12 (2) 4.59% 3.49%
Q3 2011 14 (1) -3.86% -5.69%
Q2 2011 15 4.04% 3.41%
Q1 2011 15

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here

Close
Hide
(web2)